<?xml version="1.0" encoding="UTF-8"?>

<article>
<meta-data>
<journal-meta>
<journal-name>International Archives of Cardiovascular Diseases
</journal-name>
<journal-shortname>Int Arch Cardiovasc Dis</journal-shortname>
<journal-doi>10.23937/2643-3966</journal-doi>
<issn>2643-3966</issn>
<publisher>
<publisher-name>ClinMed International Library</publisher-name>
<publisher-location>Wilmington, USA</publisher-location>
<publisher-doi-prefix>10.23937</publisher-doi-prefix>
</publisher>
</journal-meta>
<article-meta>
<article-title>
Bridging Cardiac Surgery and Interventional Cardiology in Yemen: Implementing the Heart Team Concept in a Resource Limited Healthcare System
</article-title>
<citation_author>Al-Fakih AW</citation_author>
<article-doi>10.23937/2469-5858/1510086</article-doi>
<article-description>
The interface between cardiac surgery and interventional cardiology has evolved rapidly worldwide, driven by advances in transcatheter therapies and multidisciplinary decision-making frameworks. Central to this evolution is the Heart Team concept, which integrates expertise from multiple cardiovascular disciplines to optimize outcomes in complex cardiac disease. While this model is well established in high-income countries, its implementation
</article-description>
</article-meta>
</meta-data>
<body>
<article-type>Review Article</article-type>
<volume>10</volume>
<issue>1</issue>
<access-type>OPEN ACCESS</access-type>
<article-doi>10.23937/2469-5858/1510086</article-doi>
<article-title>
Bridging Cardiac Surgery and Interventional Cardiology in Yemen: Implementing the Heart Team Concept in a Resource Limited Healthcare System
 
</article-title>
<Author-Group>
<aut id="aut1">
<label>Author-1</label>
<name>Wadhah Al-Fakih A</name>
<affiliation>
Cardiovascular Surgery and Kidney Transplant Center, Taiz, Yemen
</affiliation>
</aut>
<aut id="aut2">
<label>Author-2</label>
<name>Shaima Al-Bagoush A</name>
<affiliation>
Sana'a University, Faculty of Medicine and Health, Sana'a, Yemen
</affiliation>
</aut>
<aut id="aut3">
<label>Author-3</label>
<name>Waleed Ahmed T</name>
<affiliation>
Cardiovascular Surgery and Kidney Transplant Center, Taiz, Yemen
</affiliation>
</aut>
<aut id="aut4">
<label>Author-4</label>
<name>Faisal Ghaleb H</name>
<affiliation>
Cardiovascular Surgery and Kidney Transplant Center, Taiz, Yemen
</affiliation>
</aut>
<aut id="aut5">
<label>Author-5</label>
<name>Sami Ibrahim M</name>
<affiliation>
Cardiovascular Surgery and Kidney Transplant Center, Taiz, Yemen
</affiliation>
</aut>
<aut id="aut6">
<label>Author-6</label>
<name> Hamzah Taha A</name>
<affiliation>
Cardiovascular Surgery and Kidney Transplant Center, Taiz, Yemen
</affiliation>
</aut>
<aut id="aut7">
<label>Author-7</label>
<name>Osama AL-Helali M</name>
<affiliation>
Cardiovascular Surgery and Kidney Transplant Center, Taiz, Yemen
</affiliation>
</aut>
<aut id="aut8">
<label>Author-8</label>
<name>Maher Khaled A</name>
<affiliation>
Cardiovascular Surgery and Kidney Transplant Center, Taiz, Yemen
</affiliation>
</aut>
</Author-Group>
<author-notes>
<corres-author>
<label>Corresponding-Author</label>
<name>Wadhah Al-Fakih A</name>
<address>
 Cardiovascular Surgery and Kidney Transplant Center, Taiz, Yemen.
</address>
</corres-author>
</author-notes>
<history>
<published-date>
<day>28</day>
<month>January  </month>
<year>2026</year>
</published-date>
</history>
<citation>
<author-names>
Al-Fakih AW, Al-Bagoush AS, Ahmed WT
</author-names>
<published-year>2026</published-year>
<article-title>
Bridging Cardiac Surgery and Interventional Cardiology in Yemen: Implementing the Heart Team Concept in a Resource Limited Healthcare System
</article-title>
<journal-short-name>Int Arch Cardiovasc Dis</journal-short-name>
<article-doi>10.23937/2469-5858/1510086</article-doi>
</citation>
<permissions>
<copyright>
<copyright-year>2026</copyright-year>
<copyright-holder>Al-Fakih AW, et al. </copyright-holder>
<copyright-notes>
© This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
</copyright-notes>
</copyright>
</permissions>
<article-content>


<Abstract>
<p>
	
	
	The interface between cardiac surgery and interventional cardiology has evolved rapidly worldwide, driven by advances in transcatheter therapies and multidisciplinary decision-making frameworks. Central to this evolution is the Heart Team concept, which integrates expertise from multiple cardiovascular disciplines to optimize outcomes in complex cardiac disease. While this model is well established in high-income countries, its implementation in low-resource and conflict-affected settings such as Yemen remains limited. Yemen faces a growing burden of cardiovascular disease, characterized by a persistent prevalence of rheumatic heart disease alongside a rising incidence of ischemic heart disease. This paper provides an in-depth review of the current interface between cardiac surgery and interventional cardiology in Yemen, incorporating regional epidemiological data, system-level challenges, and clinical practice realities. Strategies for implementing a pragmatic Heart Team model adapted to local constraints are discussed, with emphasis on valvular and coronary artery disease. Multidisciplinary collaboration is proposed as a cost-effective and achievable pathway to improve cardiovascular outcomes in Yemen.
</p></Abstract>
<Keywords>
<p>
	
	
	Heart Team, Cardiac surgery, Interventional cardiology, Yemen, Rheumatic heart disease, Coronary artery disease
</p></Keywords>
<Introduction>
<p>
	
	
	Cardiovascular medicine has undergone a major transformation over the past two decades, marked by the rapid expansion of catheter-based therapies, improved imaging techniques, and evidence-based multidisciplinary care models. This evolution has significantly blurred the traditional boundaries between cardiac surgery and interventional cardiology, particularly in the management of complex coronary artery disease and valvular heart disease [1].
</p>
<p>
	The Heart Team concept was developed to address this increasing complexity by ensuring balanced, patient-centred decision-making through collaboration between cardiac surgeons, interventional cardiologists, imaging specialists, anaesthesiologists, and other healthcare professionals [2]. International guidelines now strongly endorse Heart Team discussions for patients with complex coronary anatomy, severe valvular disease, or elevated procedural risk [3,4].
</p>
<p>
	In Yemen, however, healthcare delivery occurs under severe structural, economic, and political constraints. Despite these challenges, cardiovascular disease remains a leading cause of morbidity and mortality. Understanding how the interface between cardiac surgery and interventional cardiology functions within this context is essential for improving outcomes using available resources.
</p></Introduction>
<Epidemiology-of-Cardiovascular-Disease-in-Yemen-and-the-Region>
<p>
	
	
	Cardiovascular disease represents a significant and growing public health challenge in Yemen. According to the World Health Organization, non-communicable diseases account for approximately 55-60% of all deaths in Yemen, with cardiovascular diseases constituting the largest proportion [5].
</p></Epidemiology-of-Cardiovascular-Disease-in-Yemen-and-the-Region>
<Rheumatic-Heart-Disease>
<p>
	
	
	Rheumatic heart disease (RHD) remains highly prevalent in Yemen, reflecting limited access to early diagnosis and treatment of streptococcal infections. Regional data from the Middle East and North Africa (MENA) region indicate that RHD prevalence ranges from 1 to 3 per 1,000 population, with higher rates in low-income and conflict-affected countries [6]. Yemen is considered among the countries with the highest burden of RHD, particularly affecting children and young adults, leading to premature morbidity and mortality [7].
</p></Rheumatic-Heart-Disease>
<Ischemic-Heart-Disease>
<p>
	
	
	Ischemic heart disease (IHD) is increasingly prevalent in Yemen due to rising rates of smoking, diabetes mellitus, hypertension, and physical inactivity. The Global Burden of Disease study estimates that IHD is now the leading cause of cardiovascular death in Yemen, accounting for more than 20% of total mortality [8]. Notably, Yemeni patients often present at a younger age and with more advanced disease compared with populations in high-income countries [9].
</p></Ischemic-Heart-Disease>
<Late-Presentation-and-Comorbidities>
<p>
	
	
	A defining feature of cardiovascular disease in Yemen is late presentation. Patients frequently seek care only after the development of advanced symptoms, heart failure, or irreversible end-organ damage. This is compounded by a high prevalence of anemia, malnutrition, chronic kidney disease, and infectious diseases, all of which increase procedural risk and complicate management decisions [10].
</p></Late-Presentation-and-Comorbidities>
<Cardiac-Surgery-in-Yemen-Capacity-and-Constraints>
<p>
	
	
	Cardiac surgery services in Yemen are limited to a small number of tertiary centers, primarily located in major urban areas. The scope of practice is largely confined to conventional open-heart procedures, including surgical aortic valve replacement (SAVR), mitral valve repair or replacement, and coronary artery bypass grafting (CABG) [11].
</p>
<p>
	Advanced surgical techniques such as minimally invasive cardiac surgery, robotic surgery, or mechanical circulatory support are generally unavailable. Surgical outcomes are often influenced by systemic limitations, including delayed referrals, limited preoperative optimization, restricted intensive care unit capacity, and shortages of trained personnel [12].
</p>
<p>
	Given these constraints, accurate patient selection and optimal timing of surgery are critical. These decisions cannot be made in isolation and require close collaboration with interventional cardiologists and imaging specialists.
</p></Cardiac-Surgery-in-Yemen-Capacity-and-Constraints>
<Interventional-Cardiology-Practice-in-Yemen>
<p>
	
	
	Interventional cardiology is relatively more accessible than cardiac surgery in Yemen. Most tertiary hospitals provide diagnostic coronary angiography and percutaneous coronary intervention (PCI). However, structural heart interventions such as transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair, or tricuspid valve interventions are not routinely available [13].
</p>
<p>
	Patients requiring advanced transcatheter therapies are often referred abroad, leading to inequities in access to care based on financial capability. Despite these limitations, interventional cardiologists play a pivotal role in diagnostic evaluation, hemodynamic assessment, risk stratification, and perioperative planning [14].
</p></Interventional-Cardiology-Practice-in-Yemen>
<The-Heart-Team-Concept-in-a-Yemeni>
<p>
	
	
	Current practice
	
	In most Yemeni institutions, cardiovascular decision-making remains fragmented and specialty-driven. Formal Heart Team meetings are rare, and treatment decisions are often made independently by cardiologists or surgeons without structured multidisciplinary discussion [15].
</p>
<p>
	Rationale for a Heart Team in Yemen
	
	In resource-limited settings, the consequences of inappropriate or poorly timed interventions are magnified. A Heart Team approach can help reduce futile procedures, optimize resource utilization, and improve patient outcomes without requiring substantial financial investment [16].
</p></The-Heart-Team-Concept-in-a-Yemeni>
<A-Feasible-Model>
<p>
	
	
	A pragmatic Heart Team in Yemen could include a cardiac surgeon, interventional cardiologist, echocardiography specialist, anaesthesiologist or intensivist, and senior nursing staff. Regular case discussions, even on a weekly basis, could significantly enhance decision-making quality [17].
</p></A-Feasible-Model>
<Valvular-Heart-Disease-A-Central-Interface>
<p>
	
	
	Aortic valve disease
	
	Severe aortic valve disease in Yemen is managed almost exclusively with surgical intervention. In elderly or high-risk patients, the absence of transcatheter alternatives makes multidisciplinary evaluation essential to avoid excessive procedural risk and poor outcomes [18].
</p>
<p>
	Mitral valve disease
	
	Rheumatic mitral valve disease is common and often advanced at presentation. Comprehensive echocardiographic assessment is crucial for determining repairability and surgical strategy, emphasizing the need for close collaboration between cardiologists and surgeons [19].
</p>
<p>
	Tricuspid valve disease
	
	Tricuspid regurgitation is frequently under-recognized and undertreated in Yemen. Late referral contributes to poor surgical outcomes, underscoring the importance of early identification through multidisciplinary evaluation [20].
</p></Valvular-Heart-Disease-A-Central-Interface>
<Coronary-Artery-Disease-and-Revascularization-Decisions>
<p>
	
	
	Coronary artery disease management represents a key interface between cardiac surgery and interventional cardiology. While PCI is widely practiced, CABG capacity is limited, and many patients present with complex coronary anatomy not adequately addressed by international guidelines [21].
</p>
<p>
	Heart Team discussions are essential to balance procedural risk, completeness of revascularization, long-term durability, and resource utilization in these complex cases [22].
</p></Coronary-Artery-Disease-and-Revascularization-Decisions>
<Training-Workforce-and-Future-Directions>
<p>
	
	
	The lack of cross-disciplinary training remains a major barrier to integrated cardiovascular care in Yemen. Long-term strategies should focus on joint educational initiatives, multidisciplinary case reviews, and regional or international training collaborations [23].
</p>
<p>
	Telemedicine and regional partnerships may provide opportunities to integrate advanced expertise into local decision-making processes, even in the absence of advanced technologies [24].
</p></Training-Workforce-and-Future-Directions>
<Conclusion>
<p>
	
	
	The interface between cardiac surgery and interventional cardiology in Yemen is shaped by a high burden of rheumatic and ischemic heart disease, late patient presentation, and significant resource constraints. Despite these challenges, the adoption of a structured Heart Team approach tailored to local realities represents a practical, cost-effective, and impactful strategy for improving cardiovascular care. Multidisciplinary collaboration should be viewed not as an optional enhancement, but as a fundamental requirement for delivering safe and effective cardiovascular care in Yemen.
</p></Conclusion>
<Conflict-of-Interest>
<p>
	
	
	The author declares no conflicts of interest.
</p></Conflict-of-Interest>
<Funding>
<p>
	
	
	No external funding was received for this work.
</p></Funding>
<p>
	&#38;nbsp;
</p>



<figures-and-tables>
	<text>All Figures and Tables link given in below</text>
	<link>https://clinmedjournals.org/articles/iacvd/international-archives-of-cardiovascular-diseases-iacvd-10-068.php?jid=iacvd</link>
</figures-and-tables>



</article-content>

<article-references>
<title>References</title>

		 
<ref id="ref1">
    <label>Reference-1</label>
    <mixed-citation>
					Mesana T, Rodger N, Sherrard H (2018) Heart teams: A new paradigm in health care. Can J Cardiol 34: 815-818.
				    https://pubmed.ncbi.nlm.nih.gov/29960610/
    </mixed-citation>
</ref>
<ref id="ref2">
    <label>Reference-2</label>
    <mixed-citation>
				Falk V, et al. (2019) The Heart Team approach in cardiovascular medicine. Eur J Cardiothorac Surg 55: 1-3.
				    #
    </mixed-citation>
</ref>
<ref id="ref3">
    <label>Reference-3</label>
    <mixed-citation>
				Baumgartner H, et al. (2021) 2021 ESC/EACTS Guidelines for valvular heart disease. Eur Heart J 42: 407-477.
				    #
    </mixed-citation>
</ref>
<ref id="ref4">
    <label>Reference-4</label>
    <mixed-citation>
				Otto CM, et al. (2021) 2020 ACC/AHA Guideline for valvular heart disease. Circulation 143: e72-e227.
				    #
    </mixed-citation>
</ref>
<ref id="ref5">
    <label>Reference-5</label>
    <mixed-citation>
				World Health Organization (2023) Noncommunicable diseases country profiles: Yemen. WHO.
				    #
    </mixed-citation>
</ref>
<ref id="ref6">
    <label>Reference-6</label>
    <mixed-citation>
				Watkins DA, Gregory A Roth (2017) Global burden of rheumatic heart disease. N Engl J Med 377: 713-722.
				    #
    </mixed-citation>
</ref>
<ref id="ref7">
    <label>Reference-7</label>
    <mixed-citation>
				Z&#38;uuml;hlke L, et al. (2015) Rheumatic heart disease in low-income countries. Lancet 386:227-238.
				    #
    </mixed-citation>
</ref>
<ref id="ref8">
    <label>Reference-8</label>
    <mixed-citation>
				(2020) GBD 2019 diseases and injuries collaborators. Global burden of cardiovascular diseases. Lancet 396: 1204-1222.
				    #
    </mixed-citation>
</ref>
<ref id="ref9">
    <label>Reference-9</label>
    <mixed-citation>
				Yusuf S, et al. (2014) Cardiovascular disease in low-income regions. Circulation 129: 811-822.
				    #
    </mixed-citation>
</ref>
<ref id="ref10">
    <label>Reference-10</label>
    <mixed-citation>
				Mokdad AH, et al. (2016) Health effects of war in Yemen. Lancet Glob Health 4: e559-e565.
				    #
    </mixed-citation>
</ref>
<ref id="ref11">
    <label>Reference-11</label>
    <mixed-citation>
				Ruel M, et al. (2018) Cardiac surgery in resource-limited settings. J Thorac Cardiovasc Surg 156: 1983-1991.
				    #
    </mixed-citation>
</ref>
<ref id="ref12">
    <label>Reference-12</label>
    <mixed-citation>
				Vervoort D, et al. (2020) Global cardiac surgery: Access and disparities. J Am Coll Cardiol 75: 3019-3035.
				    #
    </mixed-citation>
</ref>
<ref id="ref13">
    <label>Reference-13</label>
    <mixed-citation>
				Thourani VH, et al. (2016) TAVR versus SAVR. J Am Coll Cardiol 67: 2665-2674.
				    #
    </mixed-citation>
</ref>
<ref id="ref14">
    <label>Reference-14</label>
    <mixed-citation>
				Nishimura RA, et al. Role of imaging in valvular heart disease. JACC Cardiovasc Imaging. 2019;12:222&#38;ndash;237.
				    #
    </mixed-citation>
</ref>
<ref id="ref15">
    <label>Reference-15</label>
    <mixed-citation>
				Vervoort D, et al. (2024) Multidisciplinary decision-making beyond guidelines. Can J Cardiol 40: 275-289.
				    #
    </mixed-citation>
</ref>
<ref id="ref16">
    <label>Reference-16</label>
    <mixed-citation>
				Reddy KS (2018) The importance of teamwork in low-resource healthcare. BMJ 360: k1380.
				    #
    </mixed-citation>
</ref>
<ref id="ref17">
    <label>Reference-17</label>
    <mixed-citation>
				Matkus V, et al. (2024) The evolution of the heart team concept. Can J Cardiol 40: 290-299.
				    #
    </mixed-citation>
</ref>
<ref id="ref18">
    <label>Reference-18</label>
    <mixed-citation>
				Magruder JT, et al. (2024) Timing of intervention in aortic stenosis. Can J Cardiol 40: 201-209.
				    #
    </mixed-citation>
</ref>
<ref id="ref19">
    <label>Reference-19</label>
    <mixed-citation>
					Alaour B, Masaaki Nakase, Thomas Pilgrim (2024) Combined aortic and mitral valve disease. Can J Cardiol 40: 235-249.
				    https://pubmed.ncbi.nlm.nih.gov/37931671/
    </mixed-citation>
</ref>
<ref id="ref20">
    <label>Reference-20</label>
    <mixed-citation>
					Samim D, Chrisoula Dernektsi, Nicolas Brugger, David Reineke, Fabien Praz (2024) Contemporary approach to tricuspid regurgitation. Can J Cardiol 40: 185-200.
				    https://pubmed.ncbi.nlm.nih.gov/38052301/
    </mixed-citation>
</ref>
<ref id="ref21">
    <label>Reference-21</label>
    <mixed-citation>
				Neumann FJ, et al. (2019) ESC Guidelines on coronary revascularization. Eur Heart J 40: 87-165.
				    #
    </mixed-citation>
</ref>
<ref id="ref22">
    <label>Reference-22</label>
    <mixed-citation>
				Ruel M, et al. (2018) Hybrid coronary revascularization. Circulation 138: 255-267.
				    #
    </mixed-citation>
</ref>
<ref id="ref23">
    <label>Reference-23</label>
    <mixed-citation>
				Lee R, et al. (2020) Training in transcatheter heart disease. J Thorac Cardiovasc Surg 160: 1236-1243.
				    #
    </mixed-citation>
</ref>
<ref id="ref24">
    <label>Reference-24</label>
    <mixed-citation>
					Topol EJ (2019) High-performance medicine and digital health. Nat Med 25: 44-56.
				    https://www.sbra.be/sites/default/files/1._topol_j._e._high-performance_medicine_the_convergence_of_human_and_artificial_intelligence_nature_medicine_volume_25_january_2019.pdf
    </mixed-citation>
</ref>


</article-references>
</body>
</article>